Cytodyn Inc (CYDY)

[3X Charm]

That is a false CYDY/FDA narrative.

AND THAT IS THE PROBLEM WITH NADER. HE DOES NOT KNOW HOW TO INTERACT WITH THE FDA.

If CYDY had different information than FDA was pushing on dose requirements, Nader had the obligation to run a Phase 2 dosing trial to prove 4 doses to the FDA…. Delay a few months max.

Instead he ran a substandard full trial that was destined to fail because as stated “ everyone knows the half live of LL is 10 days.”

If LL works as is being claimed, the right, common sense course of action was to take a step back, run a short dosing study, Prove your point to FDA , get 4 dose approval and THEN RUN THE PHASE 3 with 4 doses.

Couple months delay max.

If this common sense business plan had been implemented and LL IS what we think…we would be saving lives and making money with FDA approval, in US, instead of hoping for success in Brazil a year later.

The deaths in the LL arm in the CD12 trial are on Nader. It has been proven he does not care about trial patient safety in the Pestell pleadings.

It would have been a short delay on the Phase 3 trial, but would be the proper course of action .Ask people in the industry or do some research on dosing proof… this information is easily available to verify.